MIM
PEAR

MetLife Investment Management’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

MetLife Investment Management’s Portfolio PEAR Stock Details PEAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-41,941
Closed -$49.5K – 2835
2022
Q4 		$49.5K Buy
+41,941
New +$49.5K ﹤0.01% 2762